CD8A and hepatitis C virus infection: PD-L1 reportedly suppresses T-cell proliferation and effector function, through binding PD-1, most notably on functionally ‘exhausted’ CD8+ T cells during chronic viral infections such as mouse models of lymphocytic choriomeningitis virus infection and also on CD4+ and CD8+ T cells in patients infected with HIV or hepatitis C [5–9].